Quote this publication Share Print


Opinions on drugs - Posted on Mar 19 2013

Reason for request

Re-assessment of the Actual Benefit and Improvement in Actual Benefit in accordance with article R-163-21 of the Social Security Code.


Actual benefit


The Actual Benefit of XEROQUEL LP in the treatment of schizophrenia is substantial.

Improvement in actual benefit

V (absence)

XEROQUEL LP does not provide an Improvement in Actual Benefit (IAB level V) compared with other treatments available in this indication.

Contact Us

Évaluation des médicaments

See also